In brief

On 21 July 2025, the Health Sciences Authority (HSA) revised its guidelines on the risk classification of software as a medical device (SaMD) and the qualification of clinical decision support software (CDSS).

The revised guidelines incorporate changes to improve online searchability and international alignment on terminology, provide better clarity on the classification of SaMDs under Class B and include additional criterion to determine whether or not a CDSS is considered a medical device.

In more detail

The following are the notable changes to the guidelines:

  • Refinements to terminology: The title of the guidelines has been changed to “Guidelines on Risk Classification of SaMD and Qualification of Clinical Decision Support Software (CDSS)” to improve online searchability. For better international alignment, the term “Standalone Medical Mobile Applications” has been revised to “SaMD.”
  • Class B medical device criterion for SaMDs: HSA has clarified that SaMDs will be classified as Class B if they are intended to analyze, measure or monitor (i) a vital physiological process (e.g., heart rate, blood pressure, respiratory rate, body temperature) or (ii) anatomical structure images (e.g., X-rays of bones, ultrasound images of organs, intraoral images) in order to drive clinical/patient management. This clarification is in line with HSA’s guidance on the risk classification of general medical devices.
  • Clarification on CDSS qualification: HSA has provided clarification on when CDSS would not be regulated as a medical device, i.e., where the output and recommendations of CDSS are solely based on established clinical guidelines. HSA has also provided further examples of nonmedical device CDSS.
      

Key takeaways

HSA’s continuous updates to its guidelines in relation to SaMDs, especially to bring better alignment with international standards, illustrate that HSA is closely monitoring digital health related developments and will ensure that its guidelines evolve in tandem with advancements in the medical technology space.

* * * * *

© 2025 Baker & McKenzie. Wong & Leow. All rights reserved. Baker & McKenzie. Wong & Leow is incorporated with limited liability and is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a "principal" means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an "office" means an office of any such law firm. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.

Explore More Insight